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ABSTRACT
Eukaryotic chromatin structure limits the initiation
of DNA replication spatially to chromosomal origin
zones and temporally to the ordered firing of origins
during S phase. Here, we show that the level of his-
tone H4 acetylation correlates with the frequency of
replication initiation as measured by the abundance
ofshortnascentDNAstrandswithinthehumanc-myc
and lamin B2 origins, but less well with the frequency
of initiation across the b-globin locus. Treatment
of HeLa cells with trichostatin A (TSA) reversibly
increased the acetylation level of histone H4 globally
and at these initiation sites. At all three origins, TSA
treatment transiently promoted a more dispersive
pattern of initiations, decreasing the abundance of
nascent DNA at previously preferred initiation sites
while increasing the nascent strand abundance at
lower frequency genomic initiation sites. When cells
arrested in late G1 were released into TSA, they com-
pleted S phase more rapidly than untreated cells,
possibly due to the earlier initiation from late-firing
origins, as exemplified by the b-globin origin. Thus,
TSA may modulate replication origin activity through
its effects on chromatin structure, by changing the
selection of initiation sites, and by advancing the
time at which DNA synthesis can begin at some initi-
ation sites.
INTRODUCTION
The packaging of eukaryotic genomes into nucleosomes and
higher order chromatin structures limits the access of replica-
tion factors to DNA. During the development of Xenopus
and Drosophila embryos, correlated with the onset of zygotic
transcription and global chromatin remodeling, there are
dramatic changes in replication origin usage from apparently
random initiations to more speciﬁc zones of initiation (1–5).
The effect of chromosomal position on origin activity in
Drosophila (6) and the observation that euchromatic domains
of metazoan genomes generally replicate early in S phase
whereas heterochromatic regions replicate late in S phase
(7,8) argue for a regulatory role of chromatin structure in
DNA replication.
The reversible acetylation of the N-terminal tails of histones
is a prominent chromatin modiﬁcation that is thought to alter
the degree of chromatin compaction (9). A role for reversible
histone acetylation in transcriptional regulation is well recog-
nized, such that in general HAT binding and acetylation of
histones are correlated with gene activation while HDAC
binding and deacetylation are associated with repression (10).
Several chromatin remodeling activities [FACT, CHRAC,
histone acetyltransferases (HATs), histone deacetylases
(HDACs)] have also been implicated in modulating DNA
replication origin activity (11–15). Supporting a role for
histone acetylation in the initiation phase of DNA replication,
the pre-replication complex (pre-RC) components ORC1 and
MCM2 have been shown to interact with the HAT HBO1
(11,14). Furthermore Cdc45, which associates with origins
during initiation, co-puriﬁes with the HDAC Rpd3 in budding
yeast (16). Deletion of Rpd3 from the budding yeast genome
allows many late-ﬁring replication origins to initiate DNA
synthesis earlier in S phase (17,18), and treatment of human
cells with the HDAC inhibitor trichostatin A (TSA) causes
earlier replication in S phase of normally late-replicating
imprinted genes (19).
The initiation of DNA replication in eukaryotes is regulated
spatially along chromosomes at sites known as replication
origins (20–23) and temporally during S phase through the
coordinated activation of individual replicons (24–26). In con-
trast to the simple model whereby DNA replication initiation
occurs at sites precisely marked by the origin recognition
complex (ORC) in the yeast Saccharomyces cerevisiae (27),
DNA synthesis in higher eukaryotes often begins at a number
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  Published online January 13, 2005of potential sites within a broad domain termed an initiation
zone (21,28). Examples of initiation zones include those found
at the hamster DHFR (29–32) and rhodopsin (33) loci, the
c-myc locus in human (34–37), chicken and mouse cells (38),
and the b-globin locus in human (39–41), mouse (42) and
chicken (43) cells. Within a population of cells, there are
sites within these loci that are used for replication initiation
with greater frequency than other sites; however, it is currently
unclear how this initiation site preference is determined.
Although there is conservation of ORC and other replication
initiation proteins from yeast to man, it has been difﬁcult to
identify sequence elements within mammalian replication
origins that specify ORC binding (44,45). For example, it
has been suggested that the initiation events spread over
tens of kilobases at the hamster DHFR locus do not depend
on unique sequences (46), but result from stochastic initiation
at widely distributed complexes of MCM proteins (47), the
putative replicative helicase (48–50).
In the present work, we examined the acetylation level of
histone H4 at previously described initiation sites within the
b-globin, lamin B2 and c-myc replication origin loci in human
cells and used the HDAC inhibitor TSA to investigate if
changes in histone acetylation levels at these sites correlate
with changes in replication activity. We ﬁnd that the pattern of
initiation site selection within replication origin loci in human
cells is altered upon treatment with TSA, becoming more
dispersive. Thus, preferred initiation sites become less dom-
inant while infrequently used initiation sites in the genome
become more active after treatment with TSA. We show also
that the b-globin origin can be induced to initiate DNA syn-
thesis earlier in S phase after treatment with TSA. The results
indicate that TSA can affect both the choice of initiation sites
used within replication origin loci and globally throughout the
genome as well as the time during S phase at which origins
begin DNA synthesis.
MATERIALS AND METHODS
Cell culture and drug treatments
HeLa cells were maintained in DMEM with 10% newborn calf
serum (Gibco) and 50 mg of gentamicin/ml in a humidiﬁed
5% CO2 atmosphere at 37 C. Synchronization of cells in late
G1 phase was achieved by treating subconﬂuent HeLa cells
with 200 mM mimosine (Sigma) for 24 h. Alternatively, cells
were blocked at the G1/S boundary by addition of 1 mg/ml
aphidicolin for 24 h. Treatment of cells with the histone dea-
cetylase inhibitor trichostatin A (TSA; Sigma) was at a ﬁnal
concentration of 100 or 300 ng/ml, as indicated.
Flow cytometry
For DNA content analyses, 10
6 cells were trypsinized, washed
in PBS and ﬁxed overnight at  20 C in 70% ethanol. Cells
were rehydrated in phosphate-buffered saline (PBS), treated
with 100 U of RNase for 20 min at 37 C to digest RNA,
and stained with 50 mg of propidium iodide/ml (Sigma).
DNA content was analyzed on a Becton Dickenson FACScan
ﬂow cytometer. Measurement of nucleotide incorporation
involved incubating cells in the presence of 50 mM
bromodeoxyuridine (BrdU) for 1 h prior to trypsinization
and overnight ﬁxation in 70% ethanol. Cells were washed
in PBS and stained with Alexa Fluor 488-conjugated
anti-BrdU antibody (Molecular Probes) according to the
manufacturer’s recommendation. The percentage of cells
incorporating BrdU was measured on a Becton Dickenson
FACScan ﬂow cytometer.
Western blotting
Whole-cell lysates were prepared from TSA-treated or
untreated HeLa cells and examined by SDS–PAGE and west-
ern blotting with an anti-actin antibody (Upstate Biotechno-
logy) or an antibody against acetylated-histone H4 (Upstate
Biotechnology), which recognizes histone H4 acetylated at
lysines 5, 8, 12 or 16.
Chromatin immunoprecipitation (ChIP)
TSA-treated or untreated cells were cross-linked according to
the protocol of Ritzi et al. (51) with the following modiﬁca-
tions. Cross-linked chromatin was resuspended in TE buffer
(10 mM Tris–HCl, pH 7.4, 1 mM EDTA) and sonicated
(Branson soniﬁer cell disrupter 200, 50% duty cycle, 10 s
pulses, 7 pulses with 1 min intervals) on ice. The chromatin
was digested with 0.1 U micrococcal nuclease (Sigma) per
100 mg of nucleoprotein at 37 C for 5 min to yield fragments
<500 bp. Nucleoprotein (250 mg) for each chromatin immuno-
precipitation was diluted with 11· NET (550 mM Tris–HCl,
pH 7.4, 1.65 M NaCl, 5.5 mM EDTA, 5.5% NP-40) to a ﬁnal
concentration of 1· NET. Acetylated-histone H4 antibody
or normal rabbit antiserum (Upstate Biotech) was used for
immunoprecipitation. Washing of the antibody complex and
puriﬁcation of co-precipitated DNA was carried out according
to Schepers et al. (52).
Nascent DNA
Nascent DNA was isolated by denaturing gel electrophoresis
(39,53). Brieﬂy, TSA-treated or untreated cells were trypsi-
nized and washed twice in ice-cold PBS, pelleted by centri-
fugation, and resuspended in a small volume of ice-cold PBS
with 10% glycerol. The cell suspensions were loaded into
wells of a 1.25% alkaline low-melting point agarose gel
(SeaPlaque GTG) prechilled to 4 C. Cells were lysed in the
well for 10 min before the DNA marker was loaded and the
current applied. The gel was run for 12 h at 40 V, neutralized
in 1· Tris–acetate–EDTA (TAE) buffer and stained with
ethidium bromide. The 1–2 kb nascent DNA size fraction was
excised and puriﬁed (Qiagen). The total amount of 1–2 kb
nascent DNA isolated was quantitated by OliGreen ﬂuor-
escence (Molecular Probes) and ranged from 18 to 25 fg per
cell in different preparations, consistent with previous deter-
minations (53). This method eliminates all handling of DNA
prior to size fractionation and avoids the variability inherent in
other methods of nascent DNA isolation. Nascent strand
abundances are normalized per nanogram of total nascent
DNA, determined by OliGreen staining (Molecular Probes),
inasmuch as an internal control STS whose replication is unaf-
fected by TSA is not known. As reported by others (54), this
normalization leads to somewhat higher SD values than we
have reported previously (53,55). Nevertheless, SD values are
typically <15–20% of the mean. Since the 95% prediction
interval is <40% of the indicated mean, we consider decreases
in nascent strand abundance of >40% to be signiﬁcant.
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Short (1–2 kb) nascent DNA and chromatin immunopre-
cipitated DNA was measured by quantitative real-time PCR
(Q-PCR) on either an Applied Biosystems GeneAmp 5700 or
Prism 7000 sequence detection system with ampliﬁcation
monitored by SYBR Green ﬂuorescence as described pre-
viously (55). Copy numbers were determined by comparison
to standard curves generated for each primer set by ampliﬁca-
tion of sheared, genomic DNA. The nascent strand abundance
measurements (copies/ng nascent DNA) are presented as the
means (and SD values) of triplicate analysis on at least three
independent preparations of nascent DNA. The abundance of
DNA precipitated by either anti-AcH4 or normal rabbit serum
was determined in duplicate or triplicate Q-PCRs.
PCR primers
The primer sequences deﬁning each sequence-tagged site
(STS) are available upon request. The position of each
STS in the corresponding GenBank sequence is as follows:
STS-myc1 (3896–3964, AF176208), STS-myc2 (1829–1891,
HUMMYCC), STS-myc3 (4488–4552, HUMMYCC), STS-
myc4 (7866–7946, HUMMYCC), STS-L1 (2908–2995,
M94363), STS-L2 (4039–4124, M94363), STS-L3 (4821–
4896, M94363), STS-BG1 (33029–33107, U01317), STS-
BG2 (41168–41250, U01317), STS-BG3 (54653–54728,
U01317) and STS-BG4 (62073–62147, U01317). The seq-
uences of the 10mer primers employed in Figure 8 were 50-
GTGCAATGAG-30 and 50-GGAAGACAAC-30, with 45 PCR
cycles at 94 C for 30 s, 35 C for 60 s and 72 C for 2 min.
RESULTS
Histone acetylation and initiation activity at
replication origins
There has been only limited data directly implicating histone
acetylation in controlling the initiation of DNA replication in
human cells. Therefore, we ﬁrst examined whether initiation
site selection at previously described replication origins is
correlated with the acetylation level of histones at these sites.
The human b-globin, lamin B2 and c-myc loci contain regions
characterized as bona ﬁde genetic replicators (54–56), and
maps of these origin loci are shown in Figure 1 with the
locations of sequence-tagged sites (STSs) deﬁned by speciﬁc
primer sequences. The same primer sets were used to test for
both the acetylation level of histone H4 and for replication
initiation activity (nascent strand abundance). Chromatin
immunoprecipitation was used to enrich for DNA sequences
bound to acetylated histone H4, followed by analysis using
quantitative real-time PCR (Q-PCR). Origin activity was
determined with a Q-PCR-based nascent strand abundance
assay using DNA 1–2 kb in size isolated by alkaline gel
electrophoresis. DNA of this size fraction has been shown
to comprise new, semiconservatively replicated DNA derived
from replication origins and excludes Okazaki fragments
(36,57,58). Replication initiation activity at many of these
sites has been described previously using PCR-based assays
and by other methods (34–36,39–41,43,56,59). The distances
between adjacent sequence-tagged sites within the c-myc or
b-globin loci range from 3 to 14 kb and hence reﬂect separate
initiation events. The sequence-tagged sites at the lamin B2
locus span a region of only 2 kb that is centered at STS-L2, the
location of which is  110 bp downstream of the transition
point of bidirectional replication (ori) previously mapped at
the nucleotide level (56,59). The STS-L1 and STS-L3 primers
are located 1000 bp upstream and downstream of STS-L2,
respectively, and thus may report on initiations at STS-L2
as well as at ﬂanking sites.
Comparison of the amount of cross-linked DNA immuno-
precipitated with an antibody against acetylated-histone H4
(AcH4) to that precipitated by normal rabbit sera (NRS) yields
an enrichment factor that can be used to deﬁne the relative
acetylation level of histones at the corresponding STS. The
level of histone acetylation was thus examined at several sites
spanning the human b-globin, lamin B2 and c-myc replication
origin loci (Figure 2A) and is displayed in two formats
[(AcH4-NRS)/Input and AcH4/NRS] that show similar trends
in AcH4 levels within each locus (Figure 2A). Consistent
with the presence of the b-globin locus in heterochromatin,
the AcH4 enrichment values [(AcH4-NRS)/Input] at b-globin
sites were low (maximum 0.05), whereas the c-myc
(maximum 0.25) and lamin B2 (maximum 0.35) loci showed
higher AcH4 values, as expected of early replicating,
transcribed chromatin.
Replication origin activity (nascent strand abundance) at
each STS is represented as copies per nanogram of 1–2 kb
nascent DNA (Figure 2B). The c-myc locus showed a histone
acetylation pattern that correlated well with initiation efﬁ-
ciency, with STS-myc2 showing both the highest AcH4 level
c-myc replicator
12.5 kb
myc1 myc2 myc3 myc4 STS
c-myc
c-myc locus
lamin B2 TIMM13
ori
L1 L2 L3 STS
2 kb
lamin B2 replicator
lamin B2 locus
e Gg Ag db
β-globin replicator
BG1 BG2 BG3 BG4 STS
72 kb
LCR
β-globin locus
Figure 1. Maps of human replication origin loci. The human c-myc, lamin B2
andb-globinlociarelabeledwiththelocationsofsequence-taggedsites(STSs)
analyzed by quantitative real time PCR (Q-PCR) in this work. Single-headed
arrows above the open bars represent the indicated genes. Regions comprising
the c-myc, b-globin and lamin B2 replicator elements are shown as solid
boxes. LCR, b-globin locus control region. Bent arrows, lamin B2 replication
initiation site.
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Figure 2. Relativelevelsof(A) histoneH4acetylationand(B)initiationactivityatsitesspanninghumanreplicationoriginloci.ThelevelofhistoneH4acetylation
was determined by chromatin immunoprecipitation with an anti-acetylated-histone H4 (AcH4) antibody and Q-PCR. The data are calculated and presented in two
formats. The first takes the difference between DNA precipitated by anti-AcH4 antibody and normal rabbit serum as a fraction of total input cross-linked DNA
[(AcH4-NRS)/Input)]. The second method is simply a ratio of the amount of DNA precipitated by anti-AcH4 antibody to that precipitated by normal rabbit sera
(AcH4/NRS).Replicationactivitywasdeterminedbynascentstrandabundanceassayandispresentedasanaverage(andSD)fromatleastthreeindependentnascent
DNA isolations analyzed by Q-PCR in triplicate.
328 Nucleic Acids Research, 2005, Vol. 33, No. 1and the greatest nascent strand abundance. STS-myc2 lies
within a 2.4 kb fragment of the c-myc locus shown to possess
replicator activity when placed at an ectopic site in the HeLa
genome (35,53,55). Furthermore, ChIP analysis reveals that
the 2.4 kb c-myc replicator contains preferential binding sites
for ORC, Cdc6 and MCM proteins that neighbor, but are offset
from sites with the highest levels of acetylated histone H4
[(60), M. Ghosh and M. Leffak, unpublished data]. Similarly
the lamin B2 locus shows its highest AcH4 level at STS-L2,
close to the transition point for bidirectional DNA replication
initiation(59) andthe siteofORC binding(61).Incontrast,the
late-replicating b-globin locus does not show a correlation
between basal AcH4 level and replication origin activity,
with STS-BG3 showing the highest AcH4 level but STS-BG2
displaying the greatest nascent strand abundance, consistent
withpreviousreports(39–41,62).ConverselySTS-BG4,which
corresponds to the characterized replicator element (54,63),
did not show the highest relative AcH4 level among the sites
examined in the b-globin locus. While these data suggest that
the elevated histone acetylation at the early ﬁring c-myc and
lamin B2 initiation sites may be related to activation of
initiation complexes at sites of DNA synthesis, as has been
suggested in yeast (17,18), it is nonetheless unlikely to be the
sole determinant for pre-RC binding, based on observations
that multiple cis-acting elements contribute to replicator func-
tion in mammalian cells (54–56,64). In S.cerevisiae, the ini-
tiation of replication occurs directly at sites where ORC is
bound, and although ORC is conserved in higher eukaryotes
(65), the demonstration that replication can initiate at multiple
sites spanning large domains in mammalian cells suggests that
other factors may select speciﬁc sites of initiation within a
zone determined by ORC.
TSA treatment increases bulk histone acetylation and
alters cell cycle progression
To investigate the role of histone acetylation in the initiation
of DNA replication further, we made use of trichostatin A,
a reversible inhibitor of histone deacetylases that has been
shown to increase the acetylation level of histones within
the mouse b-globin locus (66), and to affect the replication
timing of imprinted genes in human cells (19). To conﬁrm that
TSA is able to increase the acetylation level of histone H4 in
HeLa cells, logarithmically growing cells were treated with
100 ng/ml TSA for 4–24 h and harvested for protein analysis
by western blotting. As can be observed in Figure 3A, TSA
treatment greatly increased the acetylation level of histone H4
between 4 and 12 h of treatment. The AcH4 level returned to
background by 18 h after the addition of TSA, consistent with
breakdown of the drug, since either higher doses or additional
TSA treatments could maintain this and other effects for a
longer period of time (data not shown).
Deletion of the Rpd3 histone deacetylase gene from the
S.cerevisiae genome advances the timing of initiation from
late-ﬁring replication origins (17,18) and promoted quicker
completion of DNA synthesis in rpd3D (17) or rpd3D,
clb5D cells (17,18). To test whether a similar scenario exists
in human cells, we synchronized HeLa cells with mimosine, a
plant amino acid that arrests cells in late G1 phase before the
establishment of active DNA replication forks (67–70).
Mimosine-synchronized cells were released from the block
into medium containing or lacking TSA. At various times
after release, cells were harvested for examination of DNA
content by ﬂow cytometry. Similar to the effect of Rpd3 dele-
tion in yeast (17), inhibition of HDACs with TSA in
human cells promoted the progression of cells through
S phase, such that by 12 h after release <30% of cells treated
with TSA remained in S phase, whereas >80% of untreated
cells remained in S phase (Figure 3B). That the cells complet-
ing S phase more rapidly indeed received TSA is supported by
the observation that these cells arrested at G2/M and took
longer to re-populate G1 than untreated cells, consistent
with previous observations (66,71,72). In contrast to cells
released from a mimosine block, cells released from an aphi-
dicolin block into TSA did not complete S phase more quickly
than control cells (Figure 3C). Since aphidicolin arrests cells
after the establishment of replication forks, these data imply
that TSA exerts an effect on replication late in G1 phase or
early in S phase, at or near the time that replication complexes
are activated.
TSA is known to cause a wide range of cellular effects,
including cell cycle arrest, differentiation and cell death (71).
We used ﬂow cytometry to examine the DNA content of an
asynchronous population of HeLa cells treated with 100 ng/ml
TSA. Consistent with previous reports using higher drug doses
(73,74), 100 ng/ml TSA arrested cells at both the G1 and G2
acetylated histone H4
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Figure3.SingledoseTSAtreatmentinduceshyperacetylationofbulkhistones.
(A) HeLa cells treated with 100 ng/ml TSA for the indicated number of hours
were lysed and analyzed by SDS–PAGE and western blotting. (B) HeLa cells
were synchronized for 18 h with 0.2 mM mimosine before release into fresh
mediumintheabsenceorpresenceof100ng/mlTSA.Cellswereharvestedfor
analysis by flow cytometry. (C) HeLa cells were synchronized with 1 mg/ml
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of 100 ng/ml TSA.
Nucleic Acids Research, 2005, Vol. 33, No. 1 329phases of the cell cycle, most notably after 18 h of treatment
(Figure 4A). There did not appear to be an S-phase checkpoint
induced, as cells that were in the early stages of S phase during
the addition of TSA continued to replicate DNA, including
from the late-ﬁring b-globin origin (see below), and instead
arrested at G2/M. Consistent with the transient hyperacetyla-
tion of histone H4 in bulk chromatin (Figure 3), by 24 h after
TSA addition, cells successfully moved through the G2 block
and mitosis and had begun to enter another S phase. These
cells were actively synthesizing DNA as determined by the
incorporation of the nucleotide analog BrdU (Figure 4B).
Furthermore, addition of higher concentrations of TSA, or
re-addition of TSA at later time points blocked both the recov-
ery from the G2 arrest and subsequent ability to incorporate
nucleotides (Figure 4B; data not shown), consistent with the
ability of cells to degrade the drug.
TSA increases the acetylation level of histones at
replication origins
The acetylation level of histone H4 in bulk chromatin is
increased after treatment of cells with TSA (Figure 3). We
were interested to determine whether increased acetylation
also occurs to histones within replication origin loci, and
used ChIP to examine the abundance of AcH4 at each
replication origin STS in untreated HeLa cells or in cells
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330 Nucleic Acids Research, 2005, Vol. 33, No. 1treated with TSA (Figure 5). Consistent with the effect of TSA
on bulk histones, increased AcH4 levels were observed at
virtually every site examined, although differences were
observed in the magnitude and timing of the change. For
example, the largest changes observed at the c-myc locus
were <3-fold, while increases as large as 14-fold were seen
at the b-globin locus, possibly due to the higher basal AcH4
level at the c-myc locus and the heterochromatic nature of the
b-globin domain. The largest increases in AcH4 levels at the
b-globin locus occurred only upon longer treatment with TSA,
consistent with the role of HDACs in forming the repressive
chromatin structure found at late-replicating loci and the role
of HATs, which are expected to be essential to replicate
through repressive chromatin (75,76), but may be recruited
to such sites only later during S phase. Thus, the enrichment
for cells in the later stages of S phase 8 h after treatment with
TSA (Figure 4A) may account for the coordinate appearance
of AcH4 at the b-globin origin. Of interest is the observation
that the greatest increase in histone H4 acetylation occurs
at BG4, which corresponds to the genetically characterized
b-globin replicator (63).
TSA treatment alters replication origin activity
Since TSA treatment tended to even out the level of histone
acetylation across each replicator locus, we wished to deter-
mine whether TSA treatment had a similar effect on replica-
tion initiation activity. Therefore, we used nascent strand
abundanceassaystoinvestigatewhetherinitiationsatsequence
tagged sites within origin loci changed upon treatment of cells
with TSA. The data are displayed in Figure 6 as the nascent
strand copy number at each STS per nanogram of nascent
DNA. Treatment with 100 ng/ml TSA for 4 or 8 h led to both
qualitativeandquantitativechangesinthepatternofinitiations
within the c-myc, lamin B2 and b-globin origins. This treat-
ment decreased the abundance of 1–2 kb nascent strands at the
most prominent sites within the c-myc locus (Figure 6). Inter-
estingly, STS-myc2, which shows the highest level of nascent
strands under normal conditions, appeared to be most affected
by TSA treatment, with its initiation site usage decreasing to a
greater extent than that for other sites within the locus. Sites
locateddownstream ofthe replicator,including STS-myc3and
STS-myc4 were therefore used with greater frequency relative
to STS-myc2 after treatment with TSA.
Replication initiation at the lamin B2 locus appeared to be
less narrowly focused and to occur over a broader region after
treatment with TSA, such that STS-L2 no longer showed the
2- to 3-fold higher nascent strand abundance compared to
STS-L1 and STS-L3 (Figure 6). The delocalized initiation
at the lamin B2 locus correlated with the greater increases
in AcH4 levels at sites ﬂanking STS-L2. At the b-globin
locus,wefurtherobservedachangeinthepatternofreplication
initiation (Figure 6), such that STS-BG2 was no longer used
preferentially after treatment with TSA for 4 or 8 h. Although,
the activity at each STS within the b-globin locus decreased
after 4 h of TSA treatment relative to untreated cells, the
nascent strand abundance at each STS increased during the
next 4 h (8 h time point), consistent with a higher proportion of
cells in the later stages of S phase at that time (Figure 4A).
After 24 h of TSA treatment, a time by which AcH4 levels
returned to background and cells recovered from the G2 arrest,
the relative nascent strand abundance returned to pretreatment
levels, such that at the c-myc locus, we observed STS-myc2
with the greatest abundance, followed by STS-myc3,
STS-myc1 and STS-myc4 (Figure 6). The relative distribu-
tions of nascent strand abundance were also similar to pre-
treatment levels at the lamin B2 and b-globin loci. Differences
in the absolute nascent strand abundances between control
cells and cells 24 h post-TSA treatment may be explained
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Figure 6. TSA treatment alters the pattern of replication origin activity in
HeLa cells. Asynchronously growing HeLa cells were treated for 4, 8 or 24 h
with 100 ng/ml TSA and loaded on alkaline gels for isolation of 12 kb nascent
DNA. Purified nascent DNA was quantitated by OliGreen fluorescence and
quantitated by real-time PCR. The data presented are the average (and SD
values) of triplicate analysis on at least three independent preparations of
nascent DNA.
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treatment (Figure 4).
To conﬁrm that it was newly synthesized DNA whose
abundance was changed by TSA treatment, control or TSA
treated cells were pulse-labeled with BrUdR and the putative
short nascent strands isolated by alkaline electrophoresis
were immunoprecipitated with anti-BrUdR antibody. The
abundance of c-myc, lamin B2 and b-globin sequences in
the input and immunoprecipitated DNA were compared
after Q-PCR (Figure 7). The results showed that 80–100%
of the input DNA at each STS comprised nascent DNA that
could be immunoprecipitated by the anti-BrUdR antibody.
The BrUdR-labeled DNA also recapitulated the TSA-induced
decreased nascent strand abundance at the c-myc (myc2),
lamin B2 (L2) and b-globin (BG2) sites.
TSA increases nascent strand abundance at
uncharacterized sites
The absolute decreases in nascent strand abundance per
nanogram of nascent DNA at most sites after 4 h of TSA
treatment suggested that other previously inefﬁcient sites of
initiation were used more frequently after treatment with TSA.
To test this idea, short 10mer primers designed for random
ampliﬁcation of genomic DNA were used to amplify anonym-
ous sites in nascent DNA harvested from either untreated cells
or cells treated with TSA. These primers generated a set of
ampliﬁcation products 400–1500 bp in size that could be
visualized when electrophoresed through agarose and stained
with ethidium bromide (Figure 8). Comparing the intensity of
the PCR products from reactions using equivalent amounts of
template nascent DNA from either TSA-treated or untreated
cells revealed ampliﬁed products that increased, decreased
or did not change in abundance upon treatment with TSA.
These observations were seen with different 10mer primers
(Figure 8A and B) and after either 4 h (Figure 8A and B) or 8 h
(Figure 8C) of TSA treatment. The uncharacterized sites
that increase in abundance upon treatment with TSA may
compensate for the decreases observed at STSs assayed in
Figure 6, and suggests that TSA treatment may lead to a
less speciﬁc pattern of initiations throughout the genome.
TSA causes earlier initiation at a late-firing origin
To investigate whether the time of initiation from a late-ﬁring
replication origin could be altered by TSA, we examined the
nascent strand abundance at STS-BG3 which consistently
showed the highest level of AcH4 in the b-globin locus.
Nascent DNA was isolated from mimosine-synchronized
cells released into medium containing or lacking TSA, and
ampliﬁed by Q-PCR as in Figure 6 to determine nascent strand
abundance. In cells lacking TSA, we observed maximal
abundance at the b-globin STS-BG3 at 10 h after release
from mimosine arrest (Figure 9), consistent with the location
of the majority of cells in late S phase at that time (Figure 3b).
In contrast, cells treated with TSA showed maximal abund-
ance at STS-BG3 only 6 h after release from mimosine,
suggesting accelerated ﬁring of this origin in cells which com-
pleted Sphase more rapidly. We observed maximal abundance
of the early replicating STS-myc2 after 3 h of release from
mimosine in both TSA-treated and untreated cells (data not
shown), although the magnitude of the abundance for
STS-myc2 and STS-BG3 was decreased in TSA-treated cells
(Figure 9), consistent with previous observations (Figure 6).
Similarselectiveaccelerationoflateoriginﬁringwasobserved
in rpd3D yeast mutants (18).
DISCUSSION
Histone acetylation at replication initiation sites
To test the relationship between replication initiation and
chromatin structure, we used a nascent strand abundance
assay and chromatin immunoprecipitation with anti-
acetylhistone H4 antibody, respectively, to compare the
replication origin activity and levels of chromatin acetylation
at the human b-globin, lamin B2 and c-myc loci. The level
of histone H4 acetylation at initiation sites within the early
replicating c-myc and lamin B2 loci correlated with the abund-
ance of 1–2 kb nascent DNA strands at these origins, and the
site within the lamin B2 and c-myc loci that showed the high-
est basal AcH4 level coincided with sites of known pre-RC
formation or replicator activity (53,55,59,61,63). These data
are consistent with models in which histone acetylation either
contributesto,orresultsfrom,anopenchromatinstructurethat
facilitates replication initiation. Nevertheless, there are clearly
factors other than the basal level of chromosomal protein
acetylation that determine origin activity, since the HeLa
b-globin locus did not show the same correlation between
the basal AcH4 level and initiation pattern. In contrast, in
the present work TSA treatment resulted in a high degree
of AcH4 at STS-BG4 in the genetically characterized b-globin
replicator (63). A recent examination of the chicken b-globin
locus further suggested that there may exist a hierarchy
of epigenetic states relevant to replication initiation and
that even within the same locus different initiation sites
may not show the same chromatin modiﬁcations (43). Thus,
in erythroid precursor cells where the b-globin genes are not
expressed, the b-globin domain was nonetheless in a decon-
densed state and replicated early in S phase. The relative
nascent strand abundance at three initiation sites within
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Figure 7. TSA decreases the abundance of BrUdR labeled nascent strands at
primaryinitiationsites.Cellswereuntreatedortreatedwith100ng/mlTSAfor
4hpriortoa30minBrUdRpulse.ShortDNAfragments(1–2kb)wereisolated
by alkaline electrophoresis and the abundance of sequences at STS-myc2, -L2
and-BG2wasquantitatedbyQ-PCRinaliquotsofthetotalshortDNAfraction
(input) or the DNA immunoprecipitated by anti-BrUdR antibody.
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the extent of CpG methylation, and hyperacetylated histone
H3 was found at only one of the three initiation sites.
HDAC inhibition as a modifier of chromatin structure
Increasing the acetylation level of histones is expected to
loosen chromatin structure, making the DNA more accessible
to protein factors (9). To test whether acetylation contributes
to replication site selection, we treated HeLa cells with the
HDAC inhibitor TSA to increase the acetylation level of his-
tone H4 both at the bulk chromatin level and at speciﬁc chro-
mosomal sites within replication initiation zones. The extent
of the increase in AcH4 level varied among the sites investi-
gated, suggesting that there may be differences in HDAC or
HAT localization or activity among the sites, as has been
proposed previously (66,77). Targeting of HDACs to the late-
replicating heterochromatic b-globin locus, or delayed recruit-
ment of HATs may be responsible for the increase in AcH4
levels only after longer periods of TSA treatment, at a time
when the majority of cells were later in S phase, consistent
with a link between HAT recruitment and DNA replication.
Overall, the TSA-dependent increase in AcH4 varied inver-
sely with the basal level of acetylated histone H4, such that the
highly acetylated c-myc locus showed the smallest relative
changes while the heterochromatic b-globin locus showed
the greatest changes. Within the early replicating c-myc and
lamin B2 loci sites ﬂanking the primary initiation sites showed
the greatest relative increases in AcH4 with TSA treatment,
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Figure8. TSAaltersnascentstrandabundanceatuncharacterizedsites.NascentDNAisolatedfromcellstreatedwith100ng/mlTSAfor4h(AandB)or8h(C)was
amplifiedbyPCRwithdifferent10merprimersusingequalstartingamountsofDNA.Productswerepurified,runon2%agarosegelsandstainedwithEtBr(inverse
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Figure 9. CellstreatedwithTSAinitiatesynthesisfromthelate-firingb-globin
originearlierinSphase.Mimosine-synchronizedcellswerereleasedintofresh
medium or medium containing 100 ng/ml TSA for the indicated number of
hours and loaded on alkaline gels for isolation of 1–2 kb nascent DNA. The
nascent DNA was analyzed by Q-PCR in triplicate to determine the abundance
of nascent strands at STS-myc2 and STS-BG3. The data are from two inde-
pendent nascent DNA preparations and are normalized to STS-myc2.
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restrict origin activation.
TSA treatment led to decreased abundance of short nascent
strands at the primary initiation sites in the early replicating
c-myc (myc1, myc2), and lamin B2 (L2) loci. However, there
wereno consistent increases ordecreasesatthesecondary sites
examined (myc1, myc4, L1, L3). A unifying, though specu-
lative model is that chromatin acetylation induces a broad-
ening of the zone over which multiple initiations can occur and
the activation of cryptic origins, consistent with the increased
nascent strand abundance at several anonymous genomic sites
(Figure 8). Despite the earlier replication of the b-globin locus
in the presence of TSA, some of these cryptic initiations may
ﬁre before those in the b-globin locus leading to its decreased
nascent strand abundance per nanogram of nascent DNA early
during TSA treatment. Due to the very limited knowledge
regarding sites of pre-RC assembly in human cells, it is cur-
rently unclear whether TSA plays a role in regulating pre-RC
formation or whether its primary target is instead pre-RC
activation. In S.cerevisiae, deletion of the HDAC Rpd3 allows
the recruitment of Cdc45 and polymerase e to late-ﬁring ori-
gins earlier in S phase (17,18). Binding of these factors deﬁne
activated origins, suggesting that the primary effect of the
Rpd3 HDAC in yeast is not at the level of pre-RC formation.
We cannot rule out that TSA is indirectly inﬂuencing initi-
ation by acting on targets other than histones (78) or that
changes in nascent strand abundance are not due to alterations
in the rate of nascent strand maturation. Supporting the view
that nascent strand abundance reﬂects the efﬁciency of initi-
ation, we note the changes in signals at the relatively closely
spacedlaminB2andc-mycSTSs,andtheobservationthatTSA
stimulates only a subset of initiation sites and accelerates the
replication of the b-globin locus relative to that of the c-myc
locus. Therefore, some structural feature distinguishes initi-
ation sites that are stimulated in response to HDAC
inhibition from those that are not. A similar conclusion
could be drawn from the data of Pappas et al. who found that
elimination of SIR2 HDAC activity differentially restored ori-
gin activity within a panel of ARS elements in a S.cerevisiae
cdc6-4 mutant temperature-sensitive for pre-RC formation
(79), and of Aparicio et al. (18) who showed that the increased
abundance of short nascent strands early in S phase in rpd3D
yeast was due to premature initiation from late ﬁring origins.
Replication origin activity and timing
TSA signiﬁcantly decreased the abundance of short, 1–2 kb
nascent DNA strands at all of the most frequently used
initiation sites of the b-globin, lamin B2 and c-myc origins.
The decreased nascent strand abundances are not likely due to
formation of double-strand breaks that could otherwise alter
the pool of 1–2 kb nascent DNA, since although high concen-
trations of TSA can activate the ATM kinase, this activation is
not mediated by double-strand break formation (80). Consist-
ent with this interpretation, ﬂow cytometry detected no
increase in apoptotic (‘sub-G1’) cells after TSA treatment,
nor did cells arrest in Sphase. Moreover, BrUdRincorporation
showed that >80% of the short DNAs isolated by alkaline
electrophoresis comprised bona ﬁde nascent DNAs.
Although the earlier initiation of late-ﬁring replication ori-
gins (Figure 9) may have contributed to the ability of TSA-
treated cells to progress through S phase (Figure 3B), it may
not be the only factor responsible for this observation. The
experiment of Figure 3C, wherein cells were synchronized
with aphidicolin and released into medium lacking or contain-
ing TSA, addresses the question of whether faster replication
fork progression or nascent strand maturation rate contributed
to this phenomenon. Aphidicolin inhibits the replicative DNA
polymerases and synchronizes cells at the G1/S transition (81),
after the establishment of replication forks and replication
bubbles. We observed no measurable difference in S phase
progression or completion between untreated and TSA-treated
cells released from aphidicolin arrest. Aphidicolin has been
reported to synchronize cells at a point in the cell cycle  2h
after that of mimosine (70), suggesting that the ability of cells
released from mimosine into TSA to complete S phase more
rapidly may be related to the rate of activation of replication
complexes, or the activation of additional replication origins
since mimosine arrests cells prior to the establishment of
replication forks (67–70). Consistent with the latter view,
quantitation of total 1–2 kb nascent DNA strands from cells
released from a mimosine block into medium lacking or con-
taining TSA for 3, 6 or 10 h showed no signiﬁcant difference
(data not shown), although there are clearly fewer TSA-treated
cells that enter S phase (Figure 3B). Thus the initiation of
replication at additional origins probably contributes to faster
S phase completion.
The observed decreases in nascent strand abundances at the
c-myc, lamin B2 and b-globin sites per nanogram of nascent
DNA necessitates that there be increases in the abundance of
1–2 kb nascent DNA elsewhere in the genome. Indeed random
ampliﬁcation of nascent DNA demonstrated that there are
other initiation sites, as yet uncharacterized, that become
capable of initiation or are used with greater frequency
upon treatment with TSA. The relative decrease of replication
initiation at the primary c-myc, lamin B2 and b-globin origin
sites, as well as at several anonymous site, suggests that TSA
is causing earlier initiations to occur at previously unused
neighboring sites. This explanation is consistent with the
TSA-induced increase in short nascent strands per S phase
cell, the induction of new nascent strands that compensate
on a weight basis for the decrease observed at the down-
regulated initiation sites, and the more rapid completion of
S phase. Interestingly, the activation of quiescent origin sites
by TSA appears to be the reverse of what occurs during
cellular differentiation, where changes in chromatin structure
associated with tissue-speciﬁc gene expressionresultin amore
restrictive pattern of initiations (1–5).
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